PLXNA2 and prostate carcinoma: Of note, PLXNA2 signaling, found to be affected by somatic mutations in SB.06 cells, has also been found to be associated with adverse outcome in previous studies in pancreas cancer, as well as with a pro-invasive phenotype in prostate cancer.